📣 VC round data is live. Check it out!
- Public Comps
- SI-BONE
SI-BONE Valuation Multiples
Discover revenue and EBITDA valuation multiples for SI-BONE and similar public comparables like BrainsWay, Lumibird, CeriBell, SD Biosensor and more.
SI-BONE Overview
About SI-BONE
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Founded
2008
HQ

Employees
559
Website
Financials (LTM)
EV
$527M
Valuation Multiples
Start free trialSI-BONE Financials
SI-BONE reported last 12-month revenue of $212M and EBITDA of $10M.
In the same LTM period, SI-BONE generated $169M in gross profit, $10M in EBITDA, and had net loss of ($19M).
Revenue (LTM)
SI-BONE P&L
In the most recent fiscal year, SI-BONE reported revenue of $201M and EBITDA of $9M.
SI-BONE is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 4%, and net margin of (9%).
Financial data powered by Morningstar, Inc.
SI-BONE Stock Performance
SI-BONE has current market cap of $628M, and enterprise value of $527M.
Market Cap Evolution
SI-BONE's stock price is $14.17.
SI-BONE share price increased by 14.4% in the last 30 days, and decreased by 25.0% in the last year.
SI-BONE has an EPS (earnings per share) of $-0.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $527M | $628M | -2.9% | 14.4% | -8.7% | -25.0% | $-0.43 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSI-BONE Valuation Multiples
SI-BONE trades at 2.5x EV/Revenue multiple, and 52.4x EV/EBITDA.
EV / Revenue (LTM)
SI-BONE Financial Valuation Multiples
As of May 16, 2026, SI-BONE has market cap of $628M and EV of $527M.
SI-BONE has a P/E ratio of (32.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SI-BONE Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SI-BONE Margins & Growth Rates
SI-BONE grew revenue by 15% and EBITDA by 34% in the last fiscal year.
In the most recent fiscal year, SI-BONE reported gross margin of 80%, EBITDA margin of 4%, and net margin of (9%).
SI-BONE Margins
SI-BONE Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Operational KPIs
SI-BONE's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
SI-BONE's Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SI-BONE's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Competitors
SI-BONE competitors include BrainsWay, Lumibird, CeriBell, SD Biosensor, Synektik, Polynovo, Sunmax Biotechnology, Japan Lifeline, QuidelOrtho and Anteris Technologies US.
Most SI-BONE public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 10.9x | 9.9x | 58.2x | 62.5x | |||
| 2.8x | 2.7x | 14.1x | 13.2x | |||
| 5.6x | 5.1x | (10.0x) | (9.4x) | |||
| 1.2x | — | (1.3x) | — | |||
| 2.9x | 2.6x | 11.7x | 10.2x | |||
| 6.4x | 5.6x | 77.9x | 72.1x | |||
| 9.9x | — | 17.9x | — | |||
| 1.4x | 1.3x | 5.8x | 5.6x | |||
This data is available for Pro users. Sign up to see all SI-BONE competitors and their valuation data. Start Free Trial | ||||||
SI-BONE Funding History
Before going public, SI-BONE raised $80M in total equity funding, across 3 rounds.
SI-BONE Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SI-BONE
| When was SI-BONE founded? | SI-BONE was founded in 2008. |
| Where is SI-BONE headquartered? | SI-BONE is headquartered in United States. |
| How many employees does SI-BONE have? | As of today, SI-BONE has over 559 employees. |
| Who is the CEO of SI-BONE? | SI-BONE's CEO is Laura A. Francis. |
| Is SI-BONE publicly listed? | Yes, SI-BONE is a public company listed on Nasdaq. |
| What is the stock symbol of SI-BONE? | SI-BONE trades under SIBN ticker. |
| When did SI-BONE go public? | SI-BONE went public in 2018. |
| Who are competitors of SI-BONE? | SI-BONE main competitors include BrainsWay, Lumibird, CeriBell, SD Biosensor, Synektik, Polynovo, Sunmax Biotechnology, Japan Lifeline, QuidelOrtho, Anteris Technologies US. |
| What is the current market cap of SI-BONE? | SI-BONE's current market cap is $628M. |
| What is the current revenue of SI-BONE? | SI-BONE's last 12 months revenue is $212M. |
| What is the current revenue growth of SI-BONE? | SI-BONE revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of SI-BONE? | Current revenue multiple of SI-BONE is 2.5x. |
| Is SI-BONE profitable? | Yes, SI-BONE is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SI-BONE? | SI-BONE's last 12 months EBITDA is $10M. |
| What is SI-BONE's EBITDA margin? | SI-BONE's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of SI-BONE? | Current EBITDA multiple of SI-BONE is 52.4x. |
| How many companies SI-BONE has acquired to date? | SI-BONE hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies SI-BONE has invested to date? | SI-BONE hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to SI-BONE
Lists including SI-BONE
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.